News | Page 30 of 30

All

All
Seventure
Life Sciences
Digital Technologies
Sport & Performance Capital
Seed Fund Quadrivium

$TxCell announces start of phase IIb clinical trial with Ovasave® for refractory Crohn’s disease$

4 December 2014

TxCell announces start of phase IIb clinical trial with Ovasave® for refractory Crohn’s disease

Biotech & Pharmaceuticals

TxCell SA (FR0010127662 – TXCL), a biotechnology company developing novel and innovative, cost-effective personalized T cell immunotherapies using antigen specific regulatory...

Read the press release

10 November 2014

Seventure Partners Invests in Liver Diagnosis Specialist Humedics

Medtech / Connected health / Digital health

EUR 6.3 million financing round for commercialization of the LiMAx test

Read the press release

1 May 2014

Enterome Raises €10 million in Series B Fund Raising

Microbiome / Nutrition / Foodtech / Lifestyle

ENTEROME Bioscience SA, a pioneer in the development of innovative disease management solutions based on a deep understanding of the gut microbiome, is pleased to announce that...

Read the press release